Coronavirus

To educate lawyers who change the world, we cannot let this crisis go to waste

As the covid-19 pandemic continues to upend education in the US and beyond, there is an opportunity to create a new normal in how IP is taught, says Megan Carpenter, Dean of the Franklin Pierce School of Law

To educate lawyers who change the world, we cannot let this crisis go to waste
Proposal to waive TRIPS is the latest sign of deepening global IP rifts over covid-19
20 Oct 2020

Proposal to waive TRIPS is the latest sign of deepening global IP rifts over covid-19

WHO-backed proposal seeks to suspend key multilateral protections for patents and trade secrets

Despite the praise, there may be less to Moderna’s covid patent pledge than meets the eye
15 Oct 2020

Despite the praise, there may be less to Moderna’s covid patent pledge than meets the eye

The leading vaccine innovator has won plaudits for its commitment not to enforce its coronavirus-related IP rights against other mRNA inventors

Latest

View all
8 Oct 2020

The patent system’s social contract has broken down, says IP billionaire Dr Gary Michelson

Spinal surgery pioneer tells IAM that it is important to ensure the US public does not get a rough deal from rights owners Read more

23 Sep 2020

Canon IP boss speaks on adapting to the ‘new normal’

Kenichi Nagasawa explains the choices he is confronted with as covid-19 accelerates changes that were already taking place in the tech industry Read more

17 Sep 2020

40 years after Bayh-Dole, the US government’s patent strategy may be at a turning point

There is growing pressure on federal agencies to enforce their IP arising from public-private collaborations Read more

16 Sep 2020

Covid-induced changes are here to stay, Campinos and Iancu agree

Speaking during IPBC Connect plenary session, the EPO and USPTO leaders say there is no going back to the old ways and warn of decreased user engagement caused by the pandemic Read more

News

View all
1 Aug 2020

Ignore naysayers, the patent system is playing a vital role in the fight against covid-19

We have learned some important IP lessons in the months since the coronavirus pandemic surged across the world; one of which is just how crucial IP itself is to finding a way out of the crisis Read more

27 Jul 2020

Indonesia makes compulsory licensing easier as high-tech waits on key patent reform

Country paves way for possible covid-19 vaccine order, but promised protections for technology firms are taking longer than anticipated Read more

20 Jul 2020

After success of early stage covid-19 vaccine trial, Oxford University's coronavirus IP policy explained

With the promising news today that a coronavirus vaccine being developed by scientists at the university is safe and triggers an immune response, we revisit our exclusive April interview with the head of Oxford's tech transfer office in which he talks about its new, expedited, approach to granting covid-related licences Read more

7 Jul 2020

How a platform technology patent list can expedite covid-19 vaccine research

More transparency around IP ownership in this vital area will help the development of treatments designed to tackle the coronavirus Read more

Analysis

View all
10 Sep 2020

Pharma patent deal-making may be back with a bang

Following a spate of licensing deals, high-value life sciences M&A now seems to be back in business after a pandemic-induced pause Read more

9 Sep 2020

Senator Tillis leads call for biopharma patent protection in any US-India trade deal

Letter to US Trade Representative from head of the Senate's IP sub-committee comes amid growing efforts to put a mini agreement between the two countries in place before November's presidential election Read more

18 Aug 2020

AI-assisted covid-19 inventions raised new IP discussions, says scientist behind recent breakthroughs

IAM speaks to University of Michigan’s Professor Timothy Cernak about patent and licensing issues raised by recent chemical synthesis innovations Read more

17 Aug 2020

With Chinese courts back in business, FRAND is on the agenda

Xiaomi’s Wuhan litigation is just latest reminder that China’s recovery from covid-19 could give local judges first say in major SEP litigations Read more

Insights

View all
8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more